Butyrate Protects Barrier Integrity and Suppresses Immune Activation in a Caco-2/PBMC Co-Culture Model While HDAC Inhibition Mimics Butyrate in Restoring Cytokine-Induced Barrier Disruption

Low-grade inflammation and barrier disruption are increasingly acknowledged for their association with non-communicable diseases (NCDs). Short chain fatty acids (SCFAs), especially butyrate, could be a potential treatment because of their combined anti-inflammatory and barrier- protective capacities...

Descripción completa

Detalles Bibliográficos
Autores principales: Korsten, Sandra G. P. J., Vromans, Herman, Garssen, Johan, Willemsen, Linette E. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305054/
https://www.ncbi.nlm.nih.gov/pubmed/37375664
http://dx.doi.org/10.3390/nu15122760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10305054/
https://www.ncbi.nlm.nih.gov/pubmed/37375664
http://dx.doi.org/10.3390/nu15122760

Ejemplares similares